Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Baotou
Clinical trial register · China

Clinical Trials in Baotou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19282 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:17 UTC
19282
Studies in scope
all four open statuses
11840
Recruiting now
open to new participants
2032
Lead sponsors
across recruiting studies
Top sites
Beijing 5606 Shanghai 3892 Guangzhou 3359 Hangzhou 1833 Wuhan 1342
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca17 Novartis Pharmaceuticals6 Xiaguang Duan6 Boehringer Ingelheim4 Sanofi3 Eli Lilly and Company3 Beijing Tiantan Hospital3 Xuanwu Hospital, Beijing2 Janssen Research & Development, LLC2 Alexion Pharmaceuticals, Inc.2 Inner Mongolia Baogang Hospital2 Dr. Willmar Schwabe GmbH & Co. KG1 Sinocelltech Ltd.1 Changhai Hospital1 EMD Serono Research & Development Institute, Inc.1 Takeda1 Shanghai Pharmaceuticals Holding Co., Ltd1 Ton-Bridge Medical Tech. Co., Ltd1 China-Japan Friendship Hospital1 ADARx Pharmaceuticals, Inc.1 Vertex Pharmaceuticals Incorporated1 Zhejiang Yangli Pharmaceutical Technology Co., Ltd.1 China National Center for Cardiovascular Diseases1 Danyang Huichuang Medical Equipment Co., Ltd.1 Arrowhead Pharmaceuticals1 UCB Biopharma SRL1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 Tianjin Medical University Cancer Institute and Hospital1 Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd.1 Viatris Innovation GmbH1 Mabwell (Shanghai) Bioscience Co., Ltd.1 Kylonova (Xiamen) Biopharma co., LTD.1 Corxel Pharmaceuticals1 Bio-Thera Solutions1 Novo Nordisk A/S1 First Affiliated Hospital of Wannan Medical College1 Pfizer1 Chengdu Kangnuoxing Biopharma,Inc.1 Biotech Pharmaceutical Co., Ltd.1 Harbin Medical University1 Dimerix Bioscience Pty Ltd1 Eisai Inc.1 Peking University Cancer Hospital & Institute1
Site location
Beijing5606 Shanghai3892 Guangzhou3359 Hangzhou1833 Wuhan1342 Chengdu1310 Nanjing1216 Changsha1159 Chongqing1085 Fuzhou1041 Tianjin940 Zhengzhou926 Hefei909 Jinan794 Changchun642 Shenzhen585 Harbin549 Nanchang449 Nanning443 Xi'an443 Suzhou433 Shenyang406 Xiamen391 Shijiazhuang351 Lanzhou273 Bengbu218 Wenzhou189 Kunming188 Guiyang184 Qingdao172 Luoyang161 Ningbo152 Taiyuan150 Foshan144 Dalian134 Xuzhou134 Changzhou124 Haikou124 Dongguan106 Shantou102 Hong Kong99 Nantong99 Wuhu92 Wuxi84 Huizhou83 Baoding83 Anyang83 Baotou82 Zhuhai79 Guangdong76 Liuzhou71 Xi’an71 Cangzhou63 Zhongshan60 Hohhot59 Ganzhou58 Xinxiang57 Yangzhou55 Taizhou55 Guilin54 Jiangmen53 Ürümqi52 Guanzhou51 Yiwu50 Zhejiang47 Yinchuan47 Zhanjiang47 Linyi47 Zunyi46 Meizhou46 Fuyang46 Nanyang45 Zhangzhou44 Quanzhou43 Jinhua43 Changde42 Hanzhou42 Lishui42 Huzhou41 Langfang39 Huai'an39 Jiaxing37 Jining37 Fujian36 Tangshan35 Jilin City34 Xiangyang32 Henan31 Hunan31 Kaifeng31 Binzhou30 Daqing30 Xining30 Chifeng29 Shandong28 Yantai28 Changzhi27 Yichang27 Chengde27 Hengyang27 Xingtai26 Jingzhou25 Sichuan25 Hubei24 Shiyan24 Xianyang24 Weifang23 Mianyang23 Wuzhou22 Hebei22 Haerbin21 Wuwei21 Luzhou20 Lianyungang20 Jiamusi20 Deyang19 Shaoguan19 Zhenjiang19 Shanxi19 Nanchong19 Chenzhou18 Liaocheng18 Putian18 Yancheng18 Bozhou18 Anqing18 Shaoxing17 Qingyuan16 Handan16 Quzhou16 Xian15 Zibo15 Yulin15 Qinhuangdao15 Chizhou15 Maoming14 Luoyang Shi14 Shangqiu14 Guangxi14 Pingxiang13 Ha’erbin13 Guizhou13 Haidian13 Heilongjiang13 Shengyang12 Jiaozuo12 Dongyang12 Xiangtan12 Zhenzhou12 Huaian11 Guandong11 Kunshan11 Yan’an11 Nanjin11 Suqian11 Chaoyang11 Beijin11 Ma’anshan11 Longyan10 Zhuzhou10 Tianjing10 Linfen10 Jiujiang10 Ankang10 Qionghai10 Jieyang10 Baise City10 Huanggang10 Heyuan10 Guigang9 Hanzhong9 Hengshui9 Weinan9 Tongling9 Neijiang9 Chuzhou9 Zhoukou8 Tai’an8 Heze8 Yueyang8 Jiangxi8 Liupanshui8 Huaihua8 Zhaoqing8 Qinzhou8 Linhai8 Shaoyang8 Zigong8 Sanya7 Fuzhou Fujian7 Hainan7 Lu'an7 Cheng Du Shi7 Dezhou7 Shenzhen Shi7 Yibin7 Zhangjiakou7 Anhui7 Ch’ang-ch’un7 Huainan7 Sanming7 Dali7 Jinjiang7 Baoji7 Xicheng7 Dongying7 Xuchang7 Dazhou6 Meihekou6 Zhoushan6 Suining6 Shanghai Shi6 Luohe6 Naning6 Huangshi6 China6 Xuhui6 Kashgar6 Chaoyang District6 Jinzhou6 Kaili6 Puyang6 Xuancheng6 Enshi5 Lanxi5 Sanmenxia5 Changping5 Wanzhou5 Mudanjiang5 Bijie5 Changshu5 Haidian District5 Yuzhong5 Datong5 Yixing5 Yuhuan5 Tongliao5 Shihezi5 Panjin5 Yuncheng5 Jiazhuang5 Macao5 Anshan5 Zhumadian5 Dongcheng5 Qianjiang5 Benxi4 Qinghai4 Wenling4 Ningde4 Hezhou4 Jiuquan4 Taian4 Chendu4 Xianning4 Suzhu4 Gaozhou4 Pudong4 Multiple Locations4 Anning4 Jingdezhen4 Weihai4 Jiangsu4 Jiangyin4 Chaohu4 Ya'an4 Huangshan City4 Huangpu4 Yongzhou4 Ji'nan4 Qiqihar4 Dongwan3 Fuxin3 Lhasa3 Gansu3 Yunnan3 Changsha Shi3 Minhang District3 Anshun3 Shunde3 Huaibei3 Yanan3 Beihai3 Hebi3 Guankou3 Fushun3 Binhai3 Neimeng3 Jiyuan3 Zhujiang3 Leshan3 Shanwei3 Aksu3 Rizhao3 Ji’an3 Beijingcun3 Dengzhou3 Yangjiang3 Yunfu3 Shapingba3 Weihui3 Shang'ai3 Zhangjiang3 Bishan3 Chongqicun3 Yangpu3 Loudi3 Xingyi3 Xinjiang3 Guangdong Province3 Guli2 Yiyang2 Tongzhou2 Qiandongnan Miao and Dong Autonomous Prefecture2 Qiannan2 Shanhai2 Qujing2 Danyang2 Liangyugang2 Ningxia2 Jing’an2 Shatin2 Xigazê2 Hechi2 Zaozhuang2 Jiaxin2 Dandong2 Baotou Shi2 Chongqi2 Meishan2 Anxi2 Tianshui2 Meicheng2 Huayuan2 Inner Mongolia2 Fuling2 Pingdingshan2 Yichang Shi2 Maanshan2 Jingjiang2 Chibi2 Fengtai2 Xiaogan2 Yisa2 Taiwan2 Guangyuan2 Karamay2 Haozhou2 Jingmen2 Many Locations2 Xuhui District2 Macau2 Xiantao2 Jinzhong2 Changzhou Shi2 Linqing2 Lincang2 Suizhou2 Taihe Chengguanzhen2 Yixingcun2 Nan'ning2 Xicheng District2 Yichun2 Panlong2 Changle2 Yueqing2 Dangyang2 Guiping2 Dingxi2 Ninghai2 Gongshu District2 Jishou2 Hechuan2 Herbin2 Xinyang2 Rui’an2 Changlexi2 Jincheng2 Taipei2 Tongren2 Shang’ai1 Chongli1 Jihan1 Hexi District1 Zhengjiang1 Zhuozhou1 Daozhen Klau and Hmong Autonomous County in Zun'yi1 Qiandongnan Miao and Dong Autonomous Region1 Wuhang1 Hongcun1 Shushan1 Pinggu1 Binzhou Shi1 Changning1 Beiliu1 Guidong1 Guangxi Zhuang Autonomous Region1 Linxia1 Qingyang1 Luoyan1 Yuzhong District1 Fu'zhou1 Wuha1 Zunhua1 Mengzhou1 Nanle1 Xiameng1 Lianyuan1 Yongji1 GuiZhou1 HuBei1 HuNan1 Baoshan1 Xichengqu Beijing1 Yangzhou SHI1 Hongkou1 Xizang1 Beijing, China1 Chian1 Sichuan Chengdu1 Yangchun1 Lingbao1 Beijing Sheng1 Ruyang1 Jiading1 Maoming Shi1 Shijia Zhuang1 Xinzheng1 Fuding1 Zhaotong1 Wenshan Zhuang and Miao Autonomous Prefecture1 Hami1 Liu‘an1 Gulin1 Hanyang1 Yangzhong1 Chang’an1 Cili1 Lanshan1 Leiyang1 Pingjiang1 Yangcheng1 Changhua1 Xian City1 Anning, Yunnan - South Region1 Beijing, Beijing1 Cangzhou, Hebei - North Region1 Caoxian County, Shandong Province1 Changzhou, Jiangsu Province1 Chengdu, Sichuan Province1 Chongqing, Chongqing1 Chongqing, Sichuan Province1 Wujin District1 Xi'an, China1 Liaoyou1 Yingtan1 Qidong1 Puning1 Chuxiong1 Puer1 Wenshan1 Zhangjiagang1 Haizhu1 Siming1 Guangzhusi1 Jina1 Hexi District, Tianjin1 Hshijiazhuang1 Kaiping1 Chengdu, Sichuan1 Guanghzou1 Changshashi1 Hetian1 Chaozhou1 Jimsar1 Luopu1 Hengshui Shi1 Duyun1 Fengcheng1 Heifi1 Changshan1 Longgang1 Heping1 Tanjin1 Wannan1 Yushu1 Sanhe1 XI 'an City, Shaanxi Province1 Changchuan1 Beijjing1 Guangong Apt/Yuncheng1 Jinghong1 Jiancheng1 Feicheng1 Xiangshan1 Shanhu1 Chongzuo1 Laibin1 Hegang1 Shuangyashan1 Suihua1 Gengma County1 Pizhou1 Siping1 Ordos1 Shenyany1 Gu'ang'zhou1 Ningxiang1 Gannan1 Zheng'zhou1 Gui'lin1 Jiangse1 Ji'an1 Longzhou1 Dongguan Shi1 Panzhihua1 Taihe1 Dongfang1 Hubei Sheng1 Bayan Nur1 Zhangye1 Heifei1 Heihe1 Changshang1 Nanzhang Chengguanzhen1 Tongchuan1 Wuhou District1 Feixian1 Chongoing1 Sanjiaocheng1 Liangshan1 Ziyang1 Yining1 Yongcheng1 Gunan1 Jiangjin1 Wulong1 Jiayuguan1 Baiyin1 Xinle1 Louxing District1 Guang’an1 Zhenngzhou1 Chuangchun1 Wu’an1 Hengzhou1 Zhongshan Town1 Jixi1 Shancheng1 Cangzhou Shi1 Linquan County1 Xianmencun1 Zhuji1 Zhangping1 Najing1 Dexing1 Wanzai1 Wuhai1 Nayong1 Qinhuangdao Shi1 Tianmen1 Fyzhou1 Guangdong Province Guangzhou City1 Xiangyun1 Jianli City, Jingzhou City1 Jingxi1 Tengzhou Town1 Xiangyang City, Hubei Province1 Laizhou1 Anhui Sheng1 Fuqing1 Nanping1 Pu'er1 Bingjie1 Fenyang1 Linping1 Qingzhen1 Chengxiang1 Tanjing1 Daping1 Lingchuan1 Xing’an1 Daming1 Dingxing1 Zhengding1 Wenquan1 Fulingqu1 Pinghu1 Ezhou1 Beijeing1 Deyang Shi1 Foshan Shi1 Tainan1 Taoyuan1 Hangzou1 Tiyuan1 Changcun1 Xiangya1 Tongji1 Chengdoucun1 Yizheng1 Junxian1 Pingdu1 Zouping1 Huozhou1 Jiexiu1 Dazhu1 Dingzhou1 Lanfang1 Chongging1 Taishing1 Ulanhot1 Yunlin1 Tacheng1 Shangluo1 XiAn1 Chancheng District1 Liwan District1 North Street1 Nanshan District1 Gongyi1 Minhang1 Yanji1 Shenzhencun1 Jining Shi1
All 625 locations
Target enrolment
to

Trials with a site in Baotou

82 of 19282 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
China National Center for Cardiovascular Diseases
Phase 3
270
Beijing, Guangzhou, Shenzhen, Zhangjiakou, Xinxiang, Zhengzhou, Wuhan, Baotou
2026-11-01
Not yet open
Beijing Tiantan Hospital
Not applicable
570
Beijing, Baotou
2026-10-01
Recruiting
AstraZeneca
Phase 3
2,800
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dongguan
2026-09-01
Not yet open
A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension
NCT07833098Hypertension, Resistant Hypertension, Uncontrolled Hypertension
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Phase 2
240
Baotou, Beijing, Changsha, Chengdu, Chongqing, Daqing, Hebei, Hengyang
2026-09
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Baoding, Baotou, Beijing, Bozhou, Changchun, Changde, Changsha, Chengdu
2026-08-24
Recruiting
AstraZeneca
Phase 3
351
Baotou, Beijing, Changde, Changsha, Changzhou, Chengdu, Hefei, Huangshi
2026-08-21
Recruiting
Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd.
Phase 3
550
Baoding, Cangzhou, Shijiazhuang, Zhangjiakou, Baotou, Chifeng, Yinchuan, Jinan
2026-08-18
Recruiting
Chengdu Kangnuoxing Biopharma,Inc.
Phase 3
136
Beijing, Langfang, Baoding, Cangzhou, Shijiazhuang, Zhangjiakou, Zhengzhou, Baotou
2026-08-13
Recruiting
Eli Lilly and Company
Phase 2
606
Baotou, Beijing, Chengdu, Guangzhou, Jiangyin, Jinan, Pingxiang, Shanghai
2026-08-07
Not yet open
Tianjin Medical University Cancer Institute and Hospital
Phase 2
56
Baotou, Tongliao, Taiyuan, Tianjin
2026-08-01
Recruiting
AstraZeneca
Phase 3
2,000
Baotou, Beijing, Changde, Changsha, Changzhou, Chengdu, Chenzhou, Chifeng
2026-07-06
Recruiting
AstraZeneca
Phase 3
800
Baotou, Binzhou, Cangzhou, Changsha, Chengdu, Ganzhou, Haikou, Hangzhou
2026-07-06
Recruiting
Harbin Medical University
Not applicable
150
Fuzhou, Nanning, Shijiazhuang, Harbin, Qiqihar, Wuhan, Baotou, Hohhot
2026-06-10
Recruiting
Chinese Adults With Kidney Disease
NCT07522099Immunoglobulin A Nephropathy (IgAN), Complement 3 Glomerulopathy (C3G), IC-MPGN
DrugTelitacicept
ADARx Pharmaceuticals, Inc.
Phase 2
30
Shenzhen, Guiyang, Zhengzhou, Baotou, Wuxi, Yantai, Beijing, Shandong
2026-05-21
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Beijing, Lanzhou, Foshan, Guangzhou, Harbin, Changsha, Baotou, Nanjing
2026-05-11
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Guangzhou, Shijiazhuang, Harbin, Changsha, Baotou, Changzhou, Nanjing, Suzhou
2026-05-11
Recruiting
Xuanwu Hospital, Beijing
Not applicable
264
Beijing, Fuzhou, Shijiazhuang, Harbin, Nanyang, Zhengzhou, Baotou, Xi'an
2026-04-15
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
202
Fuzhou, Guangzhou, Shijiazhuang, Luoyang, Baotou, Nanjing, Suzhou, Changchun
2026-04-01
Active, closed
Sanofi
Phase 3
59
Baotou, Beijing, Chengdu, Jinan, Jingzhou, Nanning, Shenyang, Taiyuan
2026-03-12
Recruiting
Boehringer Ingelheim
Phase 3
1,325
Anyang, Baoji, Baotou, Beijing, Cangzhou, Changchun, Changsha, Chengdu
2026-02-17
Recruiting
Boehringer Ingelheim
Phase 3
286
Baotou, Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Lanzhou
2026-02-16
Recruiting
Danyang Huichuang Medical Equipment Co., Ltd.
Phase 3
320
Beijing, Shijiazhuang, Baotou, Suzhou, Xi'an, Shanghai, Taiyuan, Tianjin
2025-12-10
Active, closed
Dr. Willmar Schwabe GmbH & Co. KG
Phase 4
400
Anyang, Baotou, Beijing, Benxi, Chenzhou, Chifeng, Dalian, Harbin
2025-11-28
Active, closed
Kylonova (Xiamen) Biopharma co., LTD.
Phase 2
204
Beijing, Baotou, Changde, Chongqing, Dali, Daqing, Guangzhou, Harbin
2025-10-29
Recruiting
Xuanwu Hospital, Beijing
Not applicable
750
Guangdong, Baotou, Beijing, Bozhou, Changsha, Changzhi, Changzhou, Chifeng
2025-10-24
Recruiting
Eli Lilly and Company
Phase 2
531
Baotou, Beijing, Chengdu, Chongqing, Hangzhou, Nanchang, Nanjing, Shanghai
2025-10-22
Recruiting
Changhai Hospital
Not applicable
1,250
Baotou, Beijing, Hangzhou, Hunan, Lanzhou, Shandong, Shanghai, Yunnan
2025-10-13
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Baotou, Beijing, Bengbu, Changchun, Changsha, Chengdu, Dalian, Dongguan
2025-09-30
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
30
Baotou, Beijing, Guangzhou, Shenzhen
2025-09-19
Recruiting
Sanofi
Phase 3
942
Baotou, Beijing, Changchun, Changde, Changsha, Chengdu, Chongqing, Dalian
2025-09-17
Active, closed
Eli Lilly and Company
Phase 3
800
Baotou, Beijing, Chongqing, Harbin, Hefei, Jinan, Luoyang, Nanjing
2025-09-15
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dalian
2025-07-22
Recruiting
Takeda
Phase 3
347
Beijing, Changping, Xiamen, Guangdong, Guangzhou, Shenzhen, Changsha, Baotou
2025-07-15
Recruiting
AstraZeneca
Phase 2
987
Baotou, Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou
2025-06-27
Active, closed
Novartis Pharmaceuticals
Phase 4
1,590
Anqing, Beijing, Chongqing, Longyan, Jiamusi, Zhengzhou, Baotou, Shenyang
2025-06-17
Recruiting
AstraZeneca
Phase 3
15,100
Anqing, Anyang, Baotou, Beijing, Bozhou, Changchun, Changde, Changsha
2025-06-04
Recruiting
Pfizer
Phase 2
252
Beijing, Guangzhou, Baotou, Hohhot, Najing, Nanjing, Xuzhou, Nanchang
2025-05-20
Recruiting
Corxel Pharmaceuticals
Phase 2/3
740
Baotou, Beijing, Changchun, Guangzhou, Harbin, Kaili, Linfen, Nanyang
2025-05-15
Recruiting
Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort
NCT06963489Large Vessel Occlusion, Acute Ischemic Stroke
First Affiliated Hospital of Wannan Medical College
Observational
500
Wuhu, Baotou, Jinan, Henan, Beijing
2025-04-27
Recruiting
Arrowhead Pharmaceuticals
Phase 3
288
Beijing, Guangzhou, Guiyang, Harbin, Luoyang, Nanyang, Zhuzhou, Baotou
2025-04-24
Recruiting
Peking University Cancer Hospital & Institute
Phase 1/2
42
Neimeng, Baoding, Baotou, Beijing, Dalian, Tianjin
2025-04-08
Recruiting
AstraZeneca
Phase 2
540
Baotou, Changchun, Chengdu, Chongqing, Guangzhou, Haikou, Hefei, Hohhot
2025-03-26
Recruiting
AstraZeneca
Phase 3
11,300
Baotou, Beijing, Changchun, Changde, Changsha, Changzhou, Chengdu, Chifeng
2025-03-14
Recruiting
AstraZeneca
Phase 3
5,000
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dongwan
2025-03-03
Active, closed
Sanofi
Phase 3
216
Baotou, Beijing, Chengdu, Chongqing, Hangzhou, Jinan, Jingzhou, Nanning
2025-02-06
Not yet open
Regional Anesthesia Techniques in Breast Surgery
NCT06779656Augmentation, Fibroadenoma, Mastectomy
Xiaguang Duan
Not applicable
180
Baotou
2025-02-01
Not yet open
Inner Mongolia Baogang Hospital
Not applicable
120
Baotou
2025-02-01
Not yet open
Xiaguang Duan
Not applicable
60
Baotou
2025-02-01
Not yet open
Desflurane Potentially Induces Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Perioperative Procedures by Modulating Cdc42 and Clock Proteins
NCT06772558Avascular Necrosis of the Femoral Head, Coronary Artery Disease (CAD), Benign Prostatic Hyperplasia (BPH), Cholecystitis
DrugDesflurane
Xiaguang Duan
Not applicable
60
Baotou
2025-02-01
Not yet open
Xiaguang Duan
Not applicable
120
Baotou
2025-02-01
Not yet open
Enhanced Recovery After Urologic Surgery
NCT06789744Circumcision, Hydrocelectomy, Hernia, Renal Cyst
DrugFentanyl
Xiaguang Duan
Not applicable
150
Baotou
2025-02-01
Not yet open
Inner Mongolia Baogang Hospital
Not applicable
240
Baotou
2025-02-01
Not yet open
Xiaguang Duan
Not applicable
150
Baotou
2025-01-20
Recruiting
China-Japan Friendship Hospital
Not applicable
400
Xingtai, Zhengzhou, Baotou, Jinan, Datong, Kunming, Beijing
2025-01-01
Not yet open
Sinocelltech Ltd.
Phase 1/2
99
Baotou, Beijing, Chengdu, Guangzhou, Hangzhou, Jinan, Nanchang, Nanning
2025-01
Active, closed
AstraZeneca
Phase 2/3
432
Baotou, Beijing, Bengbu, Changchun, Changde, Changsha, Changzhou, Chengdu
2024-12-06
Recruiting
UCB Biopharma SRL
Phase 3
450
Baotou, Beijing, Bengbu, Changchun, Changsha, Changzhou, Chengdu, Guangzhou
2024-11-21
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Baotou, Beijing, Changchun, Changde, Changsha, Chengdu, Chenzhou, Dalian
2024-06-17
Recruiting
AstraZeneca
Phase 3
1,000
Baotou, Beijing, Changchun, Changsha, Chengdu, Chizhou, Chongqing, Dazhou
2024-06-17
Recruiting
AstraZeneca
Phase 3
3,850
Baotou, Beijing, Changchun, Changsha, Chengdu, Chifeng, Chongqing, Guangzhou
2024-04-12
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
584
Baotou, Beijing, Changsha, Changzhou, Chengdu, Chongqing, Guangzhou, Hangzhou
2024-03-29
Active, closed
AstraZeneca
Phase 3
2,554
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dongguan
2024-03-29
Recruiting
AstraZeneca
Phase 3
5,250
Anning, Anyang, Baotou, Beijing, Changsha, Changzhi, Chengdu, Chifeng
2024-02-21
Active, closed
Chronic Kidney Disease Registry Platform Study
NCT06117852Chronic Kidney Diseases
AstraZeneca
Observational
5,000
Baotou, Beijing, Changsha, Changzhou, Chengdu, Chongqing, Dongguan, Guangzhou
2023-11-28
Active, closed
AstraZeneca
Phase 3
1,835
Baotou, Beijing, Changsha, Chengdu, Chongqing, Deyang, Foshan, Guangzhou
2023-11-07
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Hefei, Chongqing, Guangzhou, Shenzhen, Wuhan, Baotou, Nanjing, Nanchang
2023-10-27
Active, closed
Bio-Thera Solutions
Phase 2
162
Baotou, Beijing, Changsha, Chongqing, Dalian, Fuzhou, Guangzhou, Hangzhou
2023-08-01
Active, closed
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2
80
Baotou, Beijing, Changsha, Chengdu, Chongqing, Fuyang, Guangzhou, Hengyang
2023-07-06
Recruiting
Ton-Bridge Medical Tech. Co., Ltd
Not applicable
200
Luoyang, Wuhan, Nanjing, Nanchang, Changchun, Dalian, Baotou, Kunming
2023-05-11
Recruiting
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 2
300
Beijing, Guangzhou, Luoyang, Hengshui, Daqing, Wuhan, Baotou, Huai'an
2023-04-06
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Anyang, Baoji, Baotou, Beijing, Changchun, Changsha, Chengdu, Chenzhou
2023-02-15
Active, closed
A Comparison of Contact Aspiration Versus Stent Retriever for Acute Basilar Artery Occlusion
NCT05615038Basilar Artery Occlusion, Endovascular Treatment
Beijing Tiantan Hospital
Not applicable
338
Hefei, Beijing, Anyang, Zhangzhou, Baotou
2022-11-07
Active, closed
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 2
381
Baotou, Beijing, Changchun, Guangzhou, Haikou, Luoyang, Nanchang, Nanjing
2022-09-16
Recruiting
Dimerix Bioscience Pty Ltd
Phase 3
286
Baotou, Beijing, Chengdu, Guangzhou, Hangzhou, Hohhot, Jinan, Nanchang
2022-05-30
Active, closed
Novartis Pharmaceuticals
Phase 3
1,000
Guangzhou, Zhengzhou, Changsha, Baotou, Hohhot, Nanchang, Changchun, Beijing
2021-12-16
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Baotou, Beijing, Cangzhou, Changchun, Changsha, Chaoyang District, Chengdu, Chongqing
2021-08-14
Recruiting
Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial
NCT04948749ICAD - Intracranial Atherosclerotic Disease, ICAS - Intracranial Atherosclerosis, Drug-eluting Stent, Stroke
Beijing Tiantan Hospital
Not applicable
358
Beijing, Cangzhou, Tangshan, Xingtai, Wuhan, Baotou, Hohhot, Tongliao
2021-07-02
Active, closed
Janssen Research & Development, LLC
Phase 3
1,054
Baoding, Baotou, Beijing, Bengbu, Changchun, Changzhou, Chengdu, Chongqing
2021-06-17
Active, closed
Biotech Pharmaceutical Co., Ltd.
Phase 4
171
Baotou
2021-05-15
Active, closed
Novartis Pharmaceuticals
Phase 3
345
Lanzhou, Foshan, Guangzhou, Shijiazhuang, Baotou, Hohhot, Nanjing, Nantong
2021-03-01
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
DrugsAtrasentan·Zigakibart
Novartis Pharmaceuticals
Phase 3
404
Dongguan, Fuzhou, Baotou, Nanjing, Nantong, Shanghai, Chengdu, Ürümqi
2020-12-11
Active, closed
Eisai Inc.
Phase 3
1,906
Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Changsha, Baotou, Nanjing, Changchun
2019-03-27
Rows per page Showing 1–82 of 82
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-china/city/baotou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,282 studies in total at the last sync on 14 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 82 of those studies with a site in Baotou.

How many clinical trials are recruiting in Baotou?

44 of the 82 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:17 UTC sync. A further 13 have not yet opened recruitment, 24 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Baotou), 82 studies
PhaseStudiesRecruitingShare
Phase 3412550%
Not applicable17720.7%
Phase 213815.9%
Phase 1/2313.7%
Phase 2/3323.7%
Phase 4303.7%
Observational212.4%

Most active sponsors

Lead sponsors with the most studies (Baotou)
Lead sponsorStudiesRecruiting
AstraZeneca1713
Novartis Pharmaceuticals60
Xiaguang Duan60
Boehringer Ingelheim44
Beijing Tiantan Hospital31
Eli Lilly and Company32
Sanofi31
Alexion Pharmaceuticals, Inc.21
Inner Mongolia Baogang Hospital20
Janssen Research & Development, LLC20
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.